Blog

18 Articles

Person at a microscope
Research
February 28, 2024 • 1 Min

Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer

Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.

Slide of pancreatic cancer
Research
August 14, 2023 • 2 Min

Targeting Pancreatic Cancer Cell Growth

Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.

lab and hands in blue gloves working with a syringe.
Research
February 14, 2023 • 2 Min

Brain Cancer Vaccine for Metastatic PNET

Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.

ASCO GI and Let's Win logos
Research
January 27, 2023 • 6 Min

Research Updates from ASCO GI 2023

Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.

red prescription pills on a white background
Research
August 12, 2022 • 2 Min

Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer

Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.

circular flashes of red yellow and green light against a black background
Research
May 26, 2022 • 3 Min

Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver

Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?

model of DNA structure
Research
September 7, 2021 • 2 Min

Testing a Combination for Metastatic Pancreatic Cancer

A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.

computer rendering of KRAS protein structure
Research
March 10, 2021 • 3 Min

A New Vaccine for Advanced Pancreatic Cancer

An mRNA vaccine that works against KRAS mutations is being tested with and without immunotherapy for advanced or metastatic pancreatic cancer.

microscope image of zebrafish scales in blues and greens
Research
September 22, 2020 • 2 Min

Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer

Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.

computer rendering of DNA in Brown and blue against a black background
Research
March 2, 2020 • 2 Min

Testing the Safety of an Immunotherapy Combination After Surgery

A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.

DNA helix made of metal, plastic and stained glass
Research
January 10, 2020 • 2 Min

Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers

Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.

A yellow paper model of DNA helix against a dark background
Research
July 11, 2019 • 2 Min

Immunotherapy to Attack a Common Pancreatic Cancer Mutation

Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.

A latex-gloved hand doing close lab work
Research
March 5, 2019 • 2 Min

Targeting Cancer-Associated Wasting With Experimental Immunotherapy

Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.

looking down on top of culture test tubes with red tops, against a light blue background
Research
August 3, 2018 • 2 Min

Targeting Tumor Proteins Specific to Pancreatic Cancer Cells

A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.

Earl Groce pancreatic cancer patient at Disney World
Survivor Stories
May 22, 2018 • 7 Min

One of the Luckiest Stage IV Pancreatic Cancer Patients Ever

Despite Stage IV diagnosis, Earl Groce got lucky with a quick diagnosis and acceptance to a clinical trial. Read Earl’s story about hope and a brighter future.

  • 1
  • 2